# Glycemic Variability, Gut Microbiota, and Prognosis in T2DM With ACS

> **NCT06573060** · — · UNKNOWN · sponsor: **Second Affiliated Hospital of Nanchang University** · enrollment: 120 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus
- Coronary Heart Disease

## Interventions

- **DEVICE:** Continuous glucose monitoring

## Key facts

- **NCT ID:** NCT06573060
- **Lead sponsor:** Second Affiliated Hospital of Nanchang University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-05
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06573060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06573060, "Glycemic Variability, Gut Microbiota, and Prognosis in T2DM With ACS". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06573060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*